Osteopontin splice variant as a potential marker for metastatic disease in pancreatic adenocarcinoma
about
Deep sequencing and in silico analyses identify MYB-regulated gene networks and signaling pathways in pancreatic cancer.Loss of tumor suppressor Merlin results in aberrant activation of Wnt/β-catenin signaling in cancerHuman osteopontin: Potential clinical applications in cancer (Review)Osteopontin as a discriminating marker for pancreatic cancer and chronic pancreatitis.
P2860
Osteopontin splice variant as a potential marker for metastatic disease in pancreatic adenocarcinoma
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Osteopontin splice variant as ...... e in pancreatic adenocarcinoma
@ast
Osteopontin splice variant as ...... e in pancreatic adenocarcinoma
@en
type
label
Osteopontin splice variant as ...... e in pancreatic adenocarcinoma
@ast
Osteopontin splice variant as ...... e in pancreatic adenocarcinoma
@en
prefLabel
Osteopontin splice variant as ...... e in pancreatic adenocarcinoma
@ast
Osteopontin splice variant as ...... e in pancreatic adenocarcinoma
@en
P2093
P2860
P356
P1476
Osteopontin splice variant as ...... e in pancreatic adenocarcinoma
@en
P2093
Ali A Siddiqui
Apeksha Shah
Darren Andrade
David E Loren
Elizabeth Jones
Galina Chipitsyna
Hwyda A Arafat
Thomas E Kowalski
P2860
P304
P356
10.1111/JGH.12561
P577
2014-06-01T00:00:00Z